In an interview with ET Now, Ranjit Kapadia, Sr VP Institutional Research, Centrum Broking Pvt Ltd, gives his views on Lupin’s Q2 earnings....

The Hyderabad-based company with FY12 net sales Rs 9674 crore is expected to report good results to the cheer of its investors.

According to the report, domestic formulation market size stood at Rs 58,300 crore, ranked third in terms of volume and tenth in terms of v...

Three drug majors, Lupin, Dr Reddy's, Sun Pharma have got approvals from the US health regulator to sell generic quetiapine fumarate tablet...

ET Now spoke to dealers on institutional and high networth investors’ activity in the dealing room. Following stocks were on their radar on...

AstraZeneca PLC has reported a 27 per cent drop in third-quarter profit as it took nearly half a billion dollars in charges for product lia...

Pharmac, a New Zealand Government drug funder, will fully fund a brand of Quetiapine drug made by Indian firm Dr Reddy's Laboratories.

AstraZeneca posted a 42 per cent rise in first quarter net profit on Thursday, boosted by sales of its heart drug Toprol-XL in the United S...

India will have to get its entire healthcare and pharma sector regulatory structure in place

Sales for children of antipsychotic medicines have exploded, fuelled by a 40-fold increase over nine years in the number of children diagno...